These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12366529)

  • 21. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
    Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
    Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.
    Ferretti ME; Nalli M; Biondi C; Colamussi ML; Pavan B; Traniello S; Spisani S
    Cell Signal; 2001 Apr; 13(4):233-40. PubMed ID: 11306240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F
    J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.
    Seifert R; Schultz G; Richter-Freund M; Metzger J; Wiesmüller KH; Jung G; Bessler WG; Hauschildt S
    Biochem J; 1990 May; 267(3):795-802. PubMed ID: 2160237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
    Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+.
    Fabbri E; Spisani S; Biondi C; Barbin L; Colamussi ML; Cariani A; Traniello S; Torrini I; Ferretti ME
    Biochim Biophys Acta; 1997 Dec; 1359(3):233-40. PubMed ID: 9434129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, biological activity, conformational analysis by NMR and molecular modeling of N-formyl-L-Met-L-Pro-L-Phe-OMe, a proline analogue of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OH.
    Dugas H; Laroche M; Ptak M; Labbé H
    Int J Pept Protein Res; 1993 Jun; 41(6):595-605. PubMed ID: 8394292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.
    Torrini I; Mastropietro G; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Spisani S
    Arch Pharm (Weinheim); 1998 May; 331(5):170-6. PubMed ID: 9691248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic analogs of chemotactic formylpeptides, I.: Synthesis and biological activity of For-Cys-Leu-Phe-Cys-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Lucente G; Traniello S; Spisani S
    Arch Pharm (Weinheim); 1993 Dec; 326(12):955-8. PubMed ID: 8122965
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing beta-alanine or taurine at the central position.
    Giordano C; Lucente G; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Varani K; Spisani S
    Farmaco; 2003 Nov; 58(11):1121-30. PubMed ID: 14572863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Paci M; Sette M; Di Nola A
    Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
    Torino D; Mollica A; Pinnen F; Feliciani F; Spisani S; Lucente G
    Bioorg Med Chem; 2009 Jan; 17(1):251-9. PubMed ID: 19081258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position.
    Pagani Zecchini G; Morera E; Nalli M; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational studies of synthetic tripeptide chemoattractants.
    Vertuani G; Spisani S; Boggian M; Traniello S; Scatturin A
    Int J Pept Protein Res; 1987 Apr; 29(4):525-32. PubMed ID: 3596903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Mastropietro G; Paci M; Spisani S
    Arch Pharm (Weinheim); 1996 Dec; 329(12):517-23. PubMed ID: 9038418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue.
    Mollica A; Paradisi MP; Varani K; Spisani S; Lucente G
    Bioorg Med Chem; 2006 Apr; 14(7):2253-65. PubMed ID: 16303307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
    Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
    Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.